Contribution of schizophrenia polygenic burden to longitudinal phenotypic variance in 22q11.2 deletion syndrome

[1]  T. McGlashan,et al.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. , 2002, The American journal of psychiatry.

[2]  Koenraad Van Leemput,et al.  A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI , 2015, NeuroImage.

[3]  Godfrey D Pearlson,et al.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.

[4]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[5]  Caroline A. Montojo,et al.  The 22q11.2 Deletion Syndrome as a Window into Complex Neuropsychiatric Disorders Over the Lifespan , 2014, Biological Psychiatry.

[6]  Alex V. Kotlar,et al.  Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion , 2020, Molecular Psychiatry.

[7]  T. Shaikh,et al.  Evolutionarily conserved low copy repeats (LCRs) in 22q11 mediate deletions, duplications, translocations, and genomic instability: An update and literature review , 2001, Genetics in Medicine.

[8]  Stephan Eliez,et al.  Developmental trajectories of executive functions in 22q11.2 deletion syndrome , 2016, Journal of Neurodevelopmental Disorders.

[9]  B. Morrow,et al.  Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. , 1999, American journal of human genetics.

[10]  L. Seidman,et al.  Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7 , 2018, JAMA psychiatry.

[11]  Tom R. Gaunt,et al.  Copy number variations and cognitive phenotypes in unselected populations. , 2015, JAMA.

[12]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[13]  M. Owen,et al.  Schizophrenia and the neurodevelopmental continuum:evidence from genomics , 2017, World psychiatry : official journal of the World Psychiatric Association.

[14]  S. Djurovic,et al.  Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. , 2019, JAMA psychiatry.

[15]  N. Katsanis.  The continuum of causality in human genetic disorders , 2016, Genome Biology.

[16]  Anders M. Dale,et al.  Genetic Overlap Between Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume Indicates Shared Molecular Genetic Mechanisms , 2018, Schizophrenia bulletin.

[17]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[18]  Nick C Fox,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[19]  P. Sham,et al.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways , 2018, Brain : a journal of neurology.

[20]  Olivier Delaneau,et al.  A complete tool set for molecular QTL discovery and analysis , 2016, Nature Communications.

[21]  John Wei,et al.  Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome. , 2017, The American journal of psychiatry.

[22]  M. Van der Linden,et al.  Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome. , 2014, Journal of psychiatric research.

[23]  D. Van de Ville,et al.  Dysmaturation Observed as Altered Hippocampal Functional Connectivity at Rest Is Associated With the Emergence of Positive Psychotic Symptoms in Patients With 22q11 Deletion Syndrome , 2021, Biological Psychiatry.

[24]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[25]  M. Daly,et al.  Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study. , 2018, The lancet. Psychiatry.

[26]  R. Mägi,et al.  Cohort Profile Cohort Profile : Estonian Biobank of the Estonian Genome Center , University of Tartu , 2015 .

[27]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[28]  J. Rosenfeld,et al.  Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants , 2018, Genetics in Medicine.

[29]  Michael F. Green,et al.  Mapping genomic loci implicates genes and synaptic biology in schizophrenia , 2022, Nature.

[30]  Caroline F. Wright,et al.  Common genetic variants contribute to risk of rare severe neurodevelopmental disorders , 2018, Nature.

[31]  Sunny X. Tang,et al.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[32]  R. Kahn,et al.  Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. , 2015, JAMA psychiatry.

[33]  S. Eliez,et al.  Hippocampal volume reduction in chromosome 22q11.2 deletion syndrome (22q11.2DS): A longitudinal study of morphometry and symptomatology , 2012, Psychiatry Research: Neuroimaging.

[34]  D. Posthuma,et al.  Association of Genetic Risk for Schizophrenia and Bipolar Disorder With Infant Neuromotor Development , 2018, JAMA psychiatry.

[35]  S. Scherer,et al.  Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome , 2020, Nature Medicine.

[36]  Peter J. Scambler,et al.  22q11.2 deletion syndrome. , 2015, Nature reviews. Disease primers.

[37]  Shane A. McCarthy,et al.  A Method for Checking Genomic Integrity in Cultured Cell Lines from SNP Genotyping Data , 2016, PloS one.

[38]  Shane A. McCarthy,et al.  Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.

[39]  A. Malhotra,et al.  Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders , 2019, bioRxiv.

[40]  E. Zackai,et al.  Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. , 2004, Human molecular genetics.

[41]  O. Howes,et al.  Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis , 2020, Molecular Psychiatry.

[42]  J. Vorstman,et al.  Neurodevelopmental Trajectories and Psychiatric Morbidity: Lessons Learned From the 22q11.2 Deletion Syndrome , 2021, Current Psychiatry Reports.

[43]  J. Sebat,et al.  Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia. , 2019, The American journal of psychiatry.

[44]  Stuart J. Ritchie,et al.  Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function , 2018, Nature Communications.

[45]  R. Kucherlapati,et al.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. , 1997, American journal of human genetics.

[46]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[47]  S. Eliez,et al.  Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome , 2021, Translational Psychiatry.

[48]  B. Morrow,et al.  Molecular genetics of 22q11.2 deletion syndrome , 2018, American journal of medical genetics. Part A.

[49]  Stephan Eliez,et al.  Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. , 2014, The American journal of psychiatry.

[50]  G. Kirov,et al.  Common alleles contribute to schizophrenia in CNV carriers , 2015, Molecular Psychiatry.

[51]  S. Eliez,et al.  Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS , 2019, Molecular Psychiatry.

[52]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[53]  Dmitry Isaev,et al.  Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness. , 2020, The American journal of psychiatry.

[54]  M. Owen,et al.  Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia , 2021, JAMA psychiatry.

[55]  H. Yoo,et al.  Epilepsy and Other Neuropsychiatric Manifestations in Children and Adolescents with 22q11.2 Deletion Syndrome , 2015, Journal of clinical neurology.

[56]  S. Eliez,et al.  Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome , 2019, Schizophrenia Research.

[57]  R. Brant.  Assessing proportionality in the proportional odds model for ordinal logistic regression. , 1990, Biometrics.

[58]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[59]  Allison G. Dempsey,et al.  A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders , 2012, Journal of Medical Genetics.

[60]  Erlend S. Dørum,et al.  Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes , 2018, bioRxiv.

[61]  A. Reymond,et al.  Copy number variants, diseases and gene expression. , 2009, Human molecular genetics.

[62]  Tyrone D. Cannon,et al.  Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence , 2018, Nature Genetics.

[63]  R. Mägi,et al.  Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease , 2020, Circulation. Genomic and precision medicine.

[64]  R. Mägi,et al.  Improved Imputation Accuracy of Rare and Low-Frequency Genetic Variants Using Population-Specific High-Coverage Whole-Genome Sequencing Data Based Imputation Reference Panel , 2016 .

[65]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[66]  Brian D. Ripley,et al.  Modern applied statistics with S, 4th Edition , 2002, Statistics and computing.

[67]  S A Small,et al.  Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention , 2018, Molecular Psychiatry.

[68]  B. Roe,et al.  Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. , 2000, Human molecular genetics.

[69]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[70]  D. Rujescu,et al.  Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders , 2018, The British Journal of Psychiatry.

[71]  Sunny X. Tang,et al.  Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study , 2017, Schizophrenia bulletin.

[72]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Rosenfeld,et al.  Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities. , 2016, JAMA psychiatry.

[74]  B. Browning,et al.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.

[75]  S. Eliez,et al.  Hippocampal volume reduction in 22q11.2 deletion syndrome , 2006, Neuropsychologia.

[76]  E. Bullmore,et al.  Grey and white matter microstructure is associated with polygenic risk for schizophrenia , 2021, Molecular Psychiatry.

[77]  T. van Amelsvoort,et al.  Neurobiological perspective of 22q11.2 deletion syndrome. , 2019, The lancet. Psychiatry.

[78]  C. Sumiyoshi,et al.  Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs , 2018, International journal of molecular sciences.

[79]  Giuseppe Blasi,et al.  Schizophrenia polygenic risk score predicts mnemonic hippocampal activity , 2018, Brain : a journal of neurology.

[80]  J. Buizer-Voskamp,et al.  Genetic Schizophrenia Risk Variants Jointly Modulate Total Brain and White Matter Volume , 2013, Biological Psychiatry.

[81]  I. Deary,et al.  Impact of Polygenic Risk for Schizophrenia on Cortical Structure in UK Biobank , 2019, Biological Psychiatry.

[82]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[83]  John P. Rice,et al.  A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts , 2020, Biological Psychiatry.

[84]  D. Ledbetter,et al.  Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders , 2019, Nature Communications.

[85]  Peter B. Jones,et al.  Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population. , 2016, JAMA psychiatry.

[86]  M. Owen,et al.  High rates of schizophrenia in adults with velo-cardio-facial syndrome (VCFS) , 1999, Schizophrenia Research.

[87]  Meritxell Bach Cuadra,et al.  Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): A cross-sectional and longitudinal study , 2009, Schizophrenia Research.